VIRY.CZRADAR

CVE-2026-66340

v celém archivu

zrušit filtry CZ · EN/orig

CVE-2026-66340

EPSS 0.00

Hodnocení závažnosti

6.9 CVSS 4.0 icscert CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N
5.3 CVSS 3.1 icscert CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cve.org · NVD

1 karet z 1 položek

1

Mira Hormone Monitor, Mira Android App

View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to access unauthorized health profile information, make changes to health information, cause a denial-of-service condition, disclose session token information, and obtain control of user accounts. The following versions of Mira Hormone Monitor, Mira Android App are affected: Mira Monitor Firmware 1.7.1.47 (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE…

EPSS 0.00 CVSS 9.8 CVE-2026-64934 CVE-2026-66098 CVE-2026-66340 CVE-2026-66832 CVE-2026-66875 CVE-2026-67558 CVE-2026-67568 CVE-2026-68067 Quanovate Tech Inc. zdravotnictví US

CISA Advisories ·